AIRNA
PrivateLast Round
Series B
Apr 1, 2025
Total Funding Raised
$305M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AIRNA operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series B round in April 2025.
AIRNA is a biotechnology company that develops RNA-editing therapeutics to treat rare and common diseases by leveraging its proprietary RESTORE+™ platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AIRNA Comparables
Compare AIRNA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Frequency Therapeutics | 91% | |
| Wave Life Sciences | 87% | |
| Ascidian Therapeutics | 81% |
For institutional investors. Book with your work email.
AIRNA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 1, 2025 | ||||
| Series A Extension | Jul 31, 2024 | ||||
| Series A | Sep 19, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AIRNA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeLink Ventures | Series B |
| Codon Capital | Series A |
| Forbion | Series B, Series A, Series A Extension |
| +ND Capital | Series B, Series A, Series A Extension |
| ARCH Venture Partners | Series B, Series A Extension, Series A |
| Alexandria Venture Investments | Series A, Series A Extension |
| Pathway Bioventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 82% MoM.
- Apr 22, 2026
Developing new medicines for rare and common diseases, starting with AATD.
For institutional investors. Book with your work email.
AIRNA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AIRNA's valuation, stock price, and market status.
Is AIRNA a public or private company?
AIRNA is a private company.
What is the current stock price of AIRNA?
AIRNA is a private company, so its shares have no public market price. Caplight tracks AIRNA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AIRNA worth (valuation)?
Valuation information for AIRNA is not publicly available.
Can I buy AIRNA stock?
AIRNA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AIRNA's last funding round?
AIRNA's most recent funding round was Series B on April 1, 2025.
Who are the main investors in AIRNA?
Key investors in AIRNA include Forbion, ARCH Venture Partners, Venrock.
Will AIRNA IPO soon?
No public IPO plans have been announced for AIRNA.
How can I track AIRNA secondary market activity?
Caplight tracks bids, offers, and trades in AIRNA's shares on secondary markets.